PulvinarNeuro
  • Home
  • Devices
    • First Generation Research Device
    • XCSITE-RD
  • Therapeutic Development
  • Newsroom
  • About Us

Pulvinar Neuro Partners with EPI

3/1/2022

0 Comments

 
Picture
Flavio Frohlich, PhD, associate professor, UNC Neuroscience Center, and Founder of Pulvinar Neuro, and Leah Townsend, PhD, CEO of Pulvinar Neuro
We are excited to announce a strategic partnership with Electromedical Products International, Inc. (EPI), a leading medical device company using non-invasive brain stimulation to treat psychiatric disorders. This partnership will allow us to accelerate our non-invasive brain stimulation and product development, including transcranial alternating current stimulation (tACS), individualized feedback stimulation, and cloud-enabled therapeutics for the treatment of psychiatric and neurological illnesses.
I am looking forward to working with EPI to bring the next generation of personalized non-invasive brain stimulation to market, complementary with EPI's suites of devices, which we are confident will benefit millions of patients who are looking for effective and safe treatment options.
-Dr. Leah Townsend, President of Pulvinar Neuro
EPI is the market leader in low-current, non-invasive brain stimulation and has a long-standing track record of marketing its patented, FDA-cleared Alpha-Stim technology for the treatment of anxiety, insomnia, depression, and pain. 
Closed-loop low-intensity transcranial stimulation for the treatment of CNS disorder has a very bright future ahead.
-Dr. Flavio Frohlich, Founder of Pulvinar Neuro
0 Comments



Leave a Reply.

    Archives

    February 2023
    March 2022
    September 2019

    Categories

    All

    RSS Feed

FCOI Policy
© COPYRIGHT 2023. ALL RIGHTS RESERVED.
  • Home
  • Devices
    • First Generation Research Device
    • XCSITE-RD
  • Therapeutic Development
  • Newsroom
  • About Us